Mechanisms of post-intervention arterial remodelling

Cardiovascular Research

Volumn 96, Issue 3, 2012, Pages 363-371

  Goel, Shakti A ^a   Guo, Lian Wang ^a   Liu, Bo ^a   Kent, K C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adaptive remodelling; Constrictive remodelling; ECM; EEL; Restenosis

Indexed keywords

ADAMTS1 PROTEIN; ANTIOXIDANT; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; GELATINASE INHIBITOR; HEME OXYGENASE 1; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTEGRIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; PACLITAXEL; PROBUCOL; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEOGLYCAN; RAPAMYCIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ARTERIAL REMODELLING; ARTERY; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; BALLOON; BLOOD VESSEL FUNCTION; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL TRANSFORMATION; DRUG ELUTING STENT; DRUG TARGETING; EXTERNAL ELASTIC LAMINA; EXTRACELLULAR MATRIX; HUMAN; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RESTENOSIS; REVASCULARIZATION; REVIEW; SMOOTH MUSCLE FIBER;

ANGIOPLASTY; ANIMALS; ARTERIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; RECURRENCE; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84869465695     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs276     Document Type: Review

References (69)

1. Schillinger M, Exner M, Minar E, Mlekusch W, Mullner M, Mannhalter C et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 2004;43:950-957. (Pubitemid 38352971)
2. Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res 2007;74:223-234. (Pubitemid 46517511)
3. Suwanabol PA, Kent KC, Liu B. TGF-beta and restenosis revisited: a Smad link. J Surg Res 2011;167:287-297.
4. Tsai S, Butler J, Rafii S, Liu B, Kent KC. The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg 2009;49:502-510.
5. Weintraub WS. The pathophysiology and burden of restenosis. Am J Cardiol 2007; 100:3K-9K.
6. Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg 2007;45(Suppl. A):A64-A73.
7. Agrotis A, Kalinina N, Bobik A. Transforming growth factor-beta, cell signaling and cardiovascular disorders. Curr Vasc Pharmacol 2005;3:55-61. (Pubitemid 40089527)
8. Kundi R, Hollenbeck ST, Yamanouchi D, Herman BC, Edlin R, Ryer EJ et al. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc Res 2009;84:326-335.
9. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 2000;102:1186-1191.
10. Geary RL, Nikkari ST, Wagner WD, Williams JK, Adams MR, Dean RH. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg 1998;27:96-106. discussion 106-108.
11. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Hong MK et al. Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty. J Invasive Cardiol 1996;8:1-14. (Pubitemid 126736856)
12. Pasterkamp G, Galis ZS, de Kleijn DP. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 2004;24:650-657. (Pubitemid 38451599)
13. Gertz SD, Barry WL, Gimple LW, Banai S, Perez LS, McNamara CA et al. Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits. Cardi-ovasc Res 1997;36:396-407. (Pubitemid 28037363)
14. Faxon DP, Coats W, Currier J. Remodeling of the coronary artery after vascular injury. Prog Cardiovasc Dis 1997;40:129-140. (Pubitemid 27431110)
15. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-2821.
16. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43. (Pubitemid 126426397)
17. Mintz GS, Popma JJ, Pichard AD, Kent KM, Salter LF, Chuang YC et al. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revas-cularization. J Am Coll Cardiol 1996;27:1678-1687. (Pubitemid 26198020)
18. Sangiorgi G, Taylor AJ, Farb A, Carter AJ, Edwards WD, Holmes DR et al. Histopath-ology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Am Heart J 1999;138:681-687. (Pubitemid 29471043)
19. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375. (Pubitemid 17079680)
20. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angio-plasty in the hypercholesterolemic rabbit model. Circulation 1994;89:2809-2815. (Pubitemid 24173702)
21. Smith JD, Bryant SR, Couper LL, Vary CP, Gotwals PJ, Koteliansky VE et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibro-blast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res 1999;84:1212-1222. (Pubitemid 29244783)
22. Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG et al. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation 2003;108:2819-2825. (Pubitemid 37498986)
23. Kingston PA, Sinha S, David A, Castro MG, Lowenstein PR, Heagerty AM. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angio-plasty and enhances adventitial collagen deposition. Circulation 2001;104:2595-2601. (Pubitemid 33104799)
24. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res 2003;40:37-46. (Pubitemid 36351194)
25. Mallawaarachchi CM, Weissberg PL, Siow RC. Smad7 gene transfer attenuates adven-titial cell migration and vascular remodeling after balloon injury. Arterioscler Thromb Vasc Biol 2005;25:1383-1387. (Pubitemid 40923356)
26. de Smet BJ, de Kleijn D, Hanemaaijer R, Verheijen JH, Robertus L, van Der Helm YJ et al. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig. Circulation 2000;101:2962-2967. (Pubitemid 30415888)
27. Margolin L, Fishbein I, Banai S, Golomb G, Reich R, Perez LS et al. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade. Atherosclerosis 2002; 163:269-277. (Pubitemid 34615817)
28. Sierevogel MJ, Velema E, van der Meer FJ, Nijhuis MO, Smeets M, de Kleijn DP et al. Matrix metalloproteinase inhibition reduces adventitial thickening and collagen accumulation following balloon dilation. Cardiovasc Res 2002;55:864-869.
29. Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB, King SB 3rd et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995;15:156-165.
30. Cote G, Tardif JC, Lesperance J, Lambert J, Bourassa M, Bonan R et al. Effects of pro-bucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group. Circulation 1999;99:30-35. (Pubitemid 29035954)
31. Deiner C, Schwimmbeck PL, Koehler IS, Loddenkemper C, Noutsias M, Nikol S et al. Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis 2006;189:123-132. (Pubitemid 44441287)
32. Osherov AB, Gotha L, Cheema AN, Qiang B, Strauss BH. Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy. Cardiovasc Res 2011;91:16-26.
33. Forte A, Della Corte A, De Feo M, Cerasuolo F, Cipollaro M. Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. Cardiovasc Res 2010;88:395-405.
34. Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol 2011; 31:2391-2396.
35. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 2001;89:1111-1121. (Pubitemid 34627868)
36. Wight TN. Arterial remodeling in vascular disease: a key role for hyaluronan and ver-sican. Front Biosci 2008;13:4933-4937. (Pubitemid 351599647)
37. Lafont A, Durand E, Samuel JL, Besse B, Addad F, Levy BI et al. Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty. Circulation 1999;100:1109-1115. (Pubitemid 29416238)
38. Strauss BH, Robinson R, Batchelor WB, Chisholm RJ, Ravi G, Natarajan MK et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996;79:541-550. (Pubitemid 26276914)
39. Brasselet C, Durand E, Addad F, Al Haj Zen A, Smeets MB, Laurent-Maquin D et al. Collagen and elastin cross-linking: a mechanism of constrictive remodeling after arterial injury. Am J Physiol Heart Circ Physiol 2005;289:H2228-H2233. (Pubitemid 41507377)
40. Ward MR, Kanellakis P, Ramsey D, Funder J, Bobik A. Eplerenone suppresses con-strictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries. Circulation 2001;104:467-472. (Pubitemid 32678279)
41. Kobayashi K, Yokote K, Fujimoto M, Yamashita K, Sakamoto A, Kitahara M et al. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperpla-sia with diminished matrix deposition in response to vascular injury. Circ Res 2005;96:904-912. (Pubitemid 40604975)
42. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002;91:852-859. (Pubitemid 35285084)
43. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van Rooijen N et al. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutami-nase: possible compensation by macrophage-derived factor XIII. Circ Res 2006;99:86-92. (Pubitemid 44297059)
44. Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009;29:1074-1079.
45. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700. (Pubitemid 36724933)
46. McCaffrey TA. TGF-beta signaling in atherosclerosis and restenosis. Front Biosci (Schol Ed) 2009;1:236-245.
47. Whatling C, McPheat W, Hurt-Camejo E. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. Arterioscler Thromb Vasc Biol 2004;24:10-11. (Pubitemid 38082405)
48. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogen-esis: the good, the bad, and the ugly. Circ Res 2002;90:251-262. (Pubitemid 34633925)
49. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999;85:1179-1185. (Pubitemid 30430623)
50. Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S et al. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation 2002;105:2686-2691. (Pubitemid 34596048)
51. Epstein H, Grad E, Golomb M, Koroukhov N, Edelman ER, Golomb G et al. Innate immunity has a dual effect on vascular healing: suppression and aggravation of neoin-timal formation and remodeling post-endotoxin challenge. Atherosclerosis 2008;199:41-46.
52. Langille BL, Dajnowiec D. Cross-linking vasomotor tone and vascular remodeling: a novel function for tissue transglutaminase? Circ Res 2005;96:9-11. (Pubitemid 40095749)
53. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of matrix metal-loproteinases in blood flow-induced arterial enlargement: interaction with NO. Arter-ioscler Thromb Vasc Biol 2000;20:E120-E126.
54. Bosmans JM, Vrints CJ, Kockx MM, Bult H, Cromheeke KM, Herman AG. Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation. Arterioscler Thromb Vasc Biol 1999; 19:767-776. (Pubitemid 29135183)
55. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 1996;16:1256-1262. (Pubitemid 26339713)
56. Morishita T, Tsutsui M, Shimokawa H, Horiuchi M, Tanimoto A, Suda O et al. Vascu-loprotective roles of neuronal nitric oxide synthase. FASEB J 2002;16:1994-1996.
57. Furuno Y, Morishita T, Toyohira Y, Yamada S, Ueno S, Morisada N et al. Crucial vas-culoprotective role of the whole nitric oxide synthase system in vascular lesion formation in mice: involvement of bone marrow-derived cells. Nitric Oxide 2011;25:350-359.
58. Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S et al. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol 2000;20:E96-E100.
59. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-2579. (Pubitemid 26415078)
60. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterios-cler Thromb Vasc Biol 2001;21:739-745. (Pubitemid 32448762)
61. Durand E, Al Haj Zen A, Addad F, Brasselet C, Caligiuri G, Vinchon F et al. Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. J Vasc Res 2005;42:255-265. (Pubitemid 40981132)
62. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52. (Pubitemid 29035956)
63. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001;7:693-698. (Pubitemid 32588025)
64. Bilder G, Wentz T, Leadley R, Amin D, Byan L, O'Conner B et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation 1999;99:3292-3299. (Pubitemid 29293441)
65. Fishbein I, Waltenberger J, Banai S, Rabinovich L, Chorny M, Levitzki A et al. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neoin-timal formation in rats. Arterioscler Thromb Vasc Biol 2000;20:667-676. (Pubitemid 30151679)
66. Jonsson-Rylander AC, Nilsson T, Fritsche-Danielson R, Hammarstrom A, Behrendt M, Andersson JO et al. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 2005;25:180-185. (Pubitemid 40054273)
67. Wang L, Zheng J, Bai X, Liu B, Liu CJ, Xu Q et al. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 2009;104:688-698.
68. Parfyonova Y, Plekhanova O, Solomatina M, Naumov V, Bobik A, Berk B et al. Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury. J Vasc Res 2004;41:268-276. (Pubitemid 38798160)
69. Cittadini A, Monti MG, Castiello MC, D'Arco E, Galasso G, Sorriento D et al. Insulinlike growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury. J Thromb Haemost 2009;7:1920-1928.